ArticleTherapeutic advances in hematology2013

Demographics, treatment patterns, safety, and real-world effectiveness in patients aged 70 years and over with chronic lymphocytic leukemia receiving bendamustine with or without rituximab: a retrospective study.

Kathryn S Kolibaba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.